Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
AstraZeneca Announces Approval of Calquence in China
Monday, September 04, 2023AstraZeneca has announced the approval of Calquence acalabrutinib a nextgeneration selective Brutons tyrosine kinase BTK inhibitor in China This approval is for treating adults with chronic lymphocytic leukaemia CLL or small lymphocytic lymphoma SLL...
New York Structural Biology Centre and Syncell Partner for Microscopy-Guided Proteomics
Friday, September 01, 2023The New York Structural Biology Centre NYSBC and Syncell have partnered to establish the Optoproteomics centre of excellence This initiative will be an integral component of the newly formed NYSBC Proteomics Core featuring Syncells innovative Microsc...
Ono Pharmaceutical Enters into Drug Discovery Collaboration Agreement with Twist Bioscience
Friday, September 01, 2023Ono Pharmaceutical has entered into a significant drug discovery collaboration agreement with Twist Bioscience marking a crucial step in their efforts to develop groundbreaking antibodybased therapies for autoimmune diseases
Eucure and Syncromune Enter into Technology Transfer Agreement
Thursday, August 31, 2023Eucure and Syncromune have entered into a technology transfer agreement focused on the development of SYNCT a platform technology aimed at synchronising in situ neoantigen T cell education and immunostimulation
Kyowa Kirin Receives Approval for ORKEDIA® Tablets in Japan
Thursday, August 31, 2023Kyowa Kirin announced the approval for ORKEDIA tablets mg in Japan ORKEDIA tablets is an oral calcimimetic agent that targets parathyroid hormone PTH secretion by interacting with calcium receptors on parathyroid gland cells
Taiho Pharmaceutical Announces the Launch of FGFR inhibitor “LYTGOBI® in Japan
Wednesday, August 30, 2023Taiho Pharmaceutical has introduced a new FGFR inhibitor LYTGOBI tablets mg in Japan significant for the treatment of biliary tract cancer specifically focusing on patients with FGFR genetic aberrations
BioSkryb Genomics Partners with Research Instruments
Wednesday, August 30, 2023BioSkryb Genomics announced a partnership with Research Instruments to distribute revolutionary ResolveDNA and ResolveOME single cell amplification tools to the Singapore and Southeast Asian markets
Phebra and University of Wollongong Enter into Collaboration Agreement
Tuesday, August 29, 2023Phebra and the University of Wollongong have entered into a new sixyear collaboration agreement This collaboration aims to further advance promising research and development RD endeavours including clinical trials focused on patented and targeted ars...
Taiho Pharmaceutical and Phost’in Therapeutics Announce Licence Agreement on GnT-V Inhibitor PhOx430
Tuesday, August 29, 2023Taiho Pharmaceutical and Phostin Therapeutics have entered into an option and licence agreement that outlines their collaboration regarding the development and commercialisation of a novel compound named PhOx
Specialised Therapeutics Acquires Commercialisation Rights for New Motor Neuron Disease Therapy
Monday, August 28, 2023Specialised Therapeutics has recently announced a collaboration with Treeway to bring a new therapy TW to Australia and New Zealand for the treatment of Amyotrophic Lateral Sclerosis ALS which is the most common form of Motor Neurone Disease MND
